Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 635751, 8 pages
http://dx.doi.org/10.1155/2015/635751
Research Article

Differential Associations between CDH13 Genotypes, Adiponectin Levels, and Circulating Levels of Cellular Adhesive Molecules

1Department of Research, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City 231, Taiwan
2Department of Life Science, Chinese Culture University, Taipei 111, Taiwan
3The First Cardiovascular Division, Department of Internal Medicine, Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Taoyuan 333, Taiwan
4The Division of Cardiology, Department of Internal Medicine and Cardiovascular Center, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City 231, Taiwan
5School of Medicine, Tzu Chi University, Hualien 970, Taiwan

Received 16 June 2015; Revised 2 October 2015; Accepted 4 October 2015

Academic Editor: Oreste Gualillo

Copyright © 2015 Ming-Sheng Teng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Maeda, K. Okubo, I. Shimomura, T. Funahashi, Y. Matsuzawa, and K. Matsubara, “cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1),” Biochemical and Biophysical Research Communications, vol. 221, no. 2, pp. 286–289, 1996. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Yamauchi, J. Kamon, H. Waki et al., “The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity,” Nature Medicine, vol. 7, no. 8, pp. 941–946, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Matsuzawa, T. Funahashi, S. Kihara, and I. Shimomura, “Adiponectin and metabolic syndrome,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 1, pp. 29–33, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. H. J. Yoo and K. M. Choi, “Adipokines as a novel link between obesity and atherosclerosis,” World Journal of Diabetes, vol. 5, no. 3, pp. 357–363, 2014. View at Publisher · View at Google Scholar
  5. K. Hino and H. Nagata, “Screening for adiponectin secretion regulators,” in Vitamins & Hormones, vol. 90, chapter 5, pp. 125–141, Elsevier, 2012. View at Publisher · View at Google Scholar
  6. H. Kwon and J. E. Pessin, “Adipokines mediate inflammation and insulin resistance,” Frontiers in Endocrinology, vol. 4, article 71, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Ouchi, S. Kihara, Y. Arita et al., “Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin,” Circulation, vol. 100, no. 25, pp. 2473–2476, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Ouchi, S. Kihara, Y. Arita et al., “Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through a cAMP-dependent pathway,” Circulation, vol. 102, no. 11, pp. 1296–1301, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Ouchi, S. Kihara, T. Funahashi et al., “Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue,” Circulation, vol. 107, no. 5, pp. 671–674, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Vaverkova, D. Karasek, D. Novotny et al., “Positive association of adiponectin with soluble vascular cell adhesion molecule sVCAM-1 levels in patients with vascular disease or dyslipidemia,” Atherosclerosis, vol. 197, no. 2, pp. 725–731, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Vaverkova, D. Karasek, D. Novotny et al., “Positive association of adiponectin with soluble thrombomodulin, von Willebrand factor and soluble VCAM-1 in dyslipidemic subjects,” Clinical Biochemistry, vol. 46, no. 9, pp. 766–771, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. H. O. El-Mesallamy, N. M. Hamdy, T. M. Salman, and S. M. Ibrahim, “Adiponectin and sE-selectin concentrations in relation to inflammation in obese type 2 diabetic patients with coronary heart disease,” Angiology, vol. 63, no. 2, pp. 96–102, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Fantuzzi, “Adiponectin in inflammatory and immune-mediated diseases,” Cytokine, vol. 64, no. 1, pp. 1–10, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. L. W. Hebbard, M. Garlatti, L. J. T. Young, R. D. Cardiff, R. G. Oshima, and B. Ranscht, “T-cadherin supports angiogenesis and adiponectin association with the vasculature in a mouse mammary tumor model,” Cancer Research, vol. 68, no. 5, pp. 1407–1416, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. M. S. Denzel, M.-C. Scimia, P. M. Zumstein, K. Walsh, P. Ruiz-Lozano, and B. Ranscht, “T-cadherin is critical for adiponectin-mediated cardioprotection in mice,” The Journal of Clinical Investigation, vol. 120, no. 12, pp. 4342–4352, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Yamauchi, Y. Nio, T. Maki et al., “Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions,” Nature Medicine, vol. 13, no. 3, pp. 332–339, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. S. H. Jee, J. W. Sull, J.-E. Lee et al., “Adiponectin concentrations: a genome-wide association study,” The American Journal of Human Genetics, vol. 87, no. 4, pp. 545–552, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. C.-M. Chung, T.-H. Lin, J.-W. Chen et al., “A genome-wide association study reveals a quantitative trait locus of adiponectin on CDH13 that predicts cardiometabolic outcomes,” Diabetes, vol. 60, no. 9, pp. 2417–2423, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Gao, Y.-M. Kim, P. Chen et al., “Genetic variation in CDH13 is associated with lower plasma adiponectin levels but greater adiponectin sensitivity in east Asian populations,” Diabetes, vol. 62, no. 12, pp. 4277–4283, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Wu, H. Gao, H. Li et al., “A meta-analysis of genome-wide association studies for adiponectin levels in East Asians identifies a novel locus near WDR11-FGFR2,” Human Molecular Genetics, vol. 23, no. 4, pp. 1108–1119, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. M. S. Teng, L. A. Hsu, S. Wu et al., “Association of CDH13 genotypes/haplotypes with circulating adiponectin levels, metabolic syndrome, and related metabolic phenotypes: the role of the suppression effect,” PLoS ONE, vol. 10, no. 4, Article ID e0122664, 2015. View at Publisher · View at Google Scholar
  22. A. S. Williams, D. I. Kasahara, N. G. Verbout et al., “Role of the adiponectin binding protein, T-cadherin (Cdh13), in allergic airways responses in mice,” PLoS ONE, vol. 7, no. 7, Article ID e41088, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. M.-S. Teng, L.-A. Hsu, S. Wu et al., “Mediation analysis reveals a sex-dependent association between ABO gene variants and TG/HDL-C ratio that is suppressed by sE-selectin level,” Atherosclerosis, vol. 228, no. 2, pp. 406–412, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. WHO Expert Consultation, “Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies,” The Lancet, vol. 363, no. 9403, pp. 157–163, 2004. View at Google Scholar
  25. Y.-L. Ko, L.-A. Hsu, K.-H. Hsu, Y.-H. Ko, and Y.-S. Lee, “The interactive effects of hepatic lipase gene promoter polymorphisms with sex and obesity on high-density-lipoprotein cholesterol levels in Taiwanese-Chinese,” Atherosclerosis, vol. 172, no. 1, pp. 135–142, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. T. C. Register, K. P. Burdon, L. Lenchik et al., “Variability of serum soluble intercellular adhesion molecule-1 measurements attributable to a common polymorphism,” Clinical Chemistry, vol. 50, no. 11, pp. 2185–2187, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Rothenbacher, H. Brenner, W. März, and W. Koenig, “Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers,” European Heart Journal, vol. 26, no. 16, pp. 1640–1646, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. S. G. Wannamethee, N. Sattar, A. Rumley, P. H. Whincup, L. Lennon, and D. O. Gordon, “Tissue plasminogen activator, von Willebrand factor, and risk of type 2 diabetes in older men,” Diabetes Care, vol. 31, no. 5, pp. 995–1000, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. J. L. Fargnoli, Q. Sun, D. Olenczuk et al., “Resistin is associated with biomarkers of inflammation while total and high-molecular weight adiponectin are associated with biomarkers of inflammation, insulin resistance, and endothelial function,” European Journal of Endocrinology, vol. 162, no. 2, pp. 281–288, 2010. View at Publisher · View at Google Scholar
  30. H.-H. Chou, L.-A. Hsu, S. Wu, M.-S. Teng, Y.-C. Sun, and Y.-L. Ko, “Leptin-to-adiponectin ratio is related to low grade inflammation and insulin resistance independent of obesity in non-diabetic Taiwanese: a cross-sectional cohort study,” Acta Cardiologica Sinica, vol. 30, no. 3, pp. 204–214, 2014. View at Google Scholar · View at Scopus
  31. L. Hebbard and B. Ranscht, “Multifaceted roles of Adiponectin in cancer,” Best Practice & Research: Clinical Endocrinology & Metabolism, vol. 28, no. 1, pp. 59–69, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Matsuda, Y. Fujishima, N. Maeda et al., “Positive feedback regulation between adiponectin and T-cadherin impacts adiponectin levels in tissue and plasma of male mice,” Endocrinology, vol. 156, no. 3, pp. 934–946, 2015. View at Publisher · View at Google Scholar
  33. M.-H. Lee, R. L. Klein, H. M. El-Shewy, D. K. Luttrell, and L. M. Luttrell, “The adiponectin receptors AdipoR1 and AdipoR2 activate ERK1/2 through a Src/Ras-dependent pathway and stimulate cell growth,” Biochemistry, vol. 47, no. 44, pp. 11682–11692, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. S. S. Deepa and L. Q. Dong, “Appl1: role in adiponectin signaling and beyond,” American Journal of Physiology—Endocrinology and Metabolism, vol. 296, no. 1, pp. E22–E36, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Bag and A. Anbarasu, “Revealing the strong functional association of adipor2 and cdh13 with adipoq: a gene network study,” Cell Biochemistry and Biophysics, vol. 71, no. 3, pp. 1445–1456, 2015. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Philippova, Y. Suter, S. Toggweiler et al., “T-cadherin is present on endothelial microparticles and is elevated in plasma in early atherosclerosis,” European Heart Journal, vol. 32, no. 6, pp. 760–771, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Lee, M. Kwon, and T. Park, “Network graph analysis of gene-gene interactions in genome-wide association study data,” Genomics & Informatics, vol. 10, no. 4, pp. 256–262, 2012. View at Publisher · View at Google Scholar
  38. J. H. Lee, D.-J. Shin, S. Park, S.-M. Kang, Y. Jang, and S.-H. Lee, “Association between CDH13 variants and cardiometabolic and vascular phenotypes in a Korean population,” Yonsei Medical Journal, vol. 54, no. 6, pp. 1305–1312, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. M.-L. Vuillaume, S. Naudion, G. Banneau et al., “New candidate loci identified by array-CGH in a cohort of 100 children presenting with syndromic obesity,” American Journal of Medical Genetics Part A, vol. 164, no. 8, pp. 1965–1975, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. C. Fava, E. Danese, M. Montagnana et al., “A variant upstream of the CDH13 adiponectin receptor gene and metabolic syndrome in Swedes,” The American Journal of Cardiology, vol. 108, no. 10, pp. 1432–1437, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. C. Bromhead, J. H. Miller, and F. J. McDonald, “Regulation of T-cadherin by hormones, glucocorticoid and EGF,” Gene, vol. 374, no. 1-2, pp. 58–67, 2006. View at Publisher · View at Google Scholar · View at Scopus